(Q39560470)

13 September 2017

1 reference

title

Pharmacokinetics of non-steroidal anti-inflammatory drugs (English)

1 reference

13 September 2017

0 references

1 reference

Day RO

1

1 reference

13 September 2017

Graham GG

series ordinal

2

1 reference

13 September 2017

Williams KM

series ordinal

3

1 reference

13 September 2017

publication date

1 August 1988

1 reference

Bailliere's clinical rheumatology

13 September 2017

published in

1 reference

13 September 2017

volume

2

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

363-393

1 reference

Anti-inflammatory (ibuprofen) drug therapy in rheumatoid arthritis- rate of response and lack of time dependency of plasma pharmacokinetics

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Non-steroidal anti-inflammatory drugs, plasma half-lives, and adverse reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Pharmacokinetics of ketoprofen in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

The interaction between indomethacin and probenecid. A clinical and pharmacokinetic study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Indomethacin in rheumatoid arthritis: clinical effects, pharmacokinetics, and platelet studies in responders and nonresponders

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

A double-blind crossover evaluation of naproxen and piroxicam in osteoarthritis of hip or knee

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus arteriosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Disposition of azapropazone in chronic renal and hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Comparison of two dosing schedules of flurbiprofen for patients with rheumatoid arthritis. Twice-daily versus four-times-a-day schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Non-steroid anti-inflammatory drugs: Influence of extra-cellular pH on biodistribution and pharmacological effects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Anti-inflammatory analgesic drug responders and non-responders: a clinico-pharmacological study of flurbiprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Plasma and synovial fluid pharmacokinetics and prostaglandin inhibitory effect of indoprofen in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Acute and chronic pharmacokinetic studies of slow release ketoprofen (Oruvail) in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Renal syndromes associated with nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

A prospective endoscopic study of the effect of Orudis and Oruvail on the upper gastrointestinal tract, in patients with osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Induction of salicyluric acid formation in rheumatoid arthritis patients treated with salicylates

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Effect of food and various antacids on the absorption of tenoxicam

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Clinical pharmacology of non-steroidal anti-inflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Stereoselective disposition of ibuprofen enantiomers in synovial fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Changes in salicylate serum concentration and metabolism during chronic dosing in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Tolmetin kinetics and synovial fluid prostaglandin E levels in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Enterohepatic circulation of sulindac and metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Quantitation of dose and concentration-effect relationships for fenclofenac in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Naproxen dose and concentration: response relationship in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Central and peripheral antialgesic action of aspirin-like drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Salicylate clearance, the resultant of protein binding and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Cognitive dysfunction associated with naproxen and ibuprofen in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Absorption and disposition of ibuprofen in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Influence of age, gender, and obesity on salicylate kinetics following single doses of aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

A pharmacokinetic interaction in man between phenobarbitone and fenoprofen, a new anti-inflammatory agent

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Treatment of Rheumatoid Arthritis with Fenoprofen: Comparison with Aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Ibuprofen and sulindac kinetics in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Pharmacokinetics and tolerance of slow-release indomethacin tablets in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Stereoselective disposition of ibuprofen enantiomers in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Timing optimizes sustained-release indomethacin treatment of osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Clinical pharmacokinetics of salicylates: a re-assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

The effect of organic acids on renal clearance of methotrexate in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Effect of anti-inflammatory drugs on sulphated glycosaminoglycan synthesis in aged human articular cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Pharmacokinetics of naproxen in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Diflunisal disposition and hypouricemic response in osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Salicylate metabolism: effects of age and sex in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

SALICYLATE OTOTOXICITY: A CLINICAL STUDY.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Clinical pharmacokinetics of the salicylates

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Treatment of Acute Migraine Attack: Naproxen and Placebo Compared

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Salicylate kinetics in old age

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Marked suppression by salicylate of the augmented proteoglycan synthesis in osteoarthritic cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Effects of aspirin on salivary and serum phenytoin kinetics in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Effects of diclofenac on lithium kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Pharmacokinetics of azapropazone in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Aspirin pharmacokinetics in migraine. The effect of metoclopramide

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Absorption kinetics of aspirin in man following oral administration of an aqueous solution

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Stereoselective inversion of (R)-fenoprofen to (S)-fenoprofen in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Effects of sulindac and indomethacin on renal prostaglandin synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Plasma Protein Displacement Interactions Are Rarely of Clinical Significance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Clinical Pharmacokinetics of Methotrexate1

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Incidence of Gastric Lesions in Patients with Rheumatic Disease on Chronic Aspirin Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Sulindac metabolism: the importance of an intact colon

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Multicentre trial of naproxen and phenylbutazone in acute gout

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Effect of antacids on the bioavailability of diflunisal in the fasting and postprandial states.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Relation of naproxen kinetics to effect on platelet prostaglandin release in men and dysmenorrheic women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Naproxen pharmacokinetics in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Naproxen pharmacokinetics in patients with rheumatoid arthritis during active polyarticular inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Naproxen kinetics and disease activity in rheumatoid arthritis: a within-patient study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Effect of aluminum hydroxide on diflunisal absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Comparative multiple dose kinetics of two formulations of indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Importance of drug enantiomers in clinical pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

The stereoselective uptake of ibuprofen enantiomers into adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

Pharmacokinetic Studies on Diclofenac Sodium in Young and Old Volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

The pharmacokinetics of diclofenac sodium following intravenous and oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

The influence of food on the absorption of diclofenac as determined by the urinary excretion of the unchanged drug and its major metabolites during chronic administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2888%2980019-0

7 January 2021

10.1016/S0950-3579(88)80019-0

Identifiers

DOI

1 reference

13 September 2017

1 reference